Japan Committee Proposes IND Registry And Biobank To Drive Cancer Drug Research
This article was originally published in PharmAsia News
Executive Summary
A Japanese cancer drug research committee proposed establishing an investigational new drug registration system and biobank to spur cancer drug clinical research and development